These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33566305)

  • 1. Curcumin suppresses tumor growth of gemcitabine-resistant non-small cell lung cancer by regulating lncRNA-MEG3 and PTEN signaling.
    Gao L; Shao T; Zheng W; Ding J
    Clin Transl Oncol; 2021 Jul; 23(7):1386-1393. PubMed ID: 33566305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginsenoside Rg3 suppresses the growth of gemcitabine-resistant pancreatic cancer cells by upregulating lncRNA-CASC2 and activating PTEN signaling.
    Zou J; Su H; Zou C; Liang X; Fei Z
    J Biochem Mol Toxicol; 2020 Jun; 34(6):e22480. PubMed ID: 32104955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non‑coding RNA MEG3 inhibits cell migration and invasion of non‑small cell lung cancer cells by regulating the miR‑21‑5p/PTEN axis.
    Lv D; Bi Q; Li Y; Deng J; Wu N; Hao S; Zhao M
    Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulation of lncRNA-AC078883.3 and microRNA-19a is involved in the development of chemoresistance to cisplatin via modulating signaling pathway of PTEN/AKT.
    Xing S; Qu Y; Li C; Huang A; Tong S; Wu C; Fan K
    J Cell Physiol; 2019 Dec; 234(12):22657-22665. PubMed ID: 31111480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA MEG3 impacts proliferation, invasion, and migration of ovarian cancer cells through regulating PTEN.
    Wang J; Xu W; He Y; Xia Q; Liu S
    Inflamm Res; 2018 Dec; 67(11-12):927-936. PubMed ID: 30310931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin suppresses the malignancy of non-small cell lung cancer by modulating the circ-PRKCA/miR-384/ITGB1 pathway.
    Xu X; Zhang X; Zhang Y; Wang Z
    Biomed Pharmacother; 2021 Jun; 138():111439. PubMed ID: 33684690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA MEG3 Suppresses the Tumorigenesis of Hemangioma by Sponging miR-494 and Regulating PTEN/ PI3K/AKT Pathway.
    Dai Y; Wan Y; Qiu M; Wang S; Pan C; Wang Y; Ou J
    Cell Physiol Biochem; 2018; 51(6):2872-2886. PubMed ID: 30562741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of Gemcitabine-resistance-related gene and polymorphism of ribonucleotide reductase M1 gene promoter in Gemcitabine-resistant A549/Gem and NCI-H460/Gem cell lines].
    Liu XQ; Wang WX; Lin L; Song ST
    Zhonghua Zhong Liu Za Zhi; 2010 Jan; 32(1):17-21. PubMed ID: 20211060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA MEG3 inhibits proliferation and promotes apoptosis of synovial cells in rats with knee osteoarthritis by regulating PTEN.
    Han K; Wang FR; Yu MQ; Xu B
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5242-5248. PubMed ID: 32495857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA MEG3 promotes the sensitivity of vincristine by inhibiting autophagy in lung cancer chemotherapy.
    Xia H; Qu XL; Liu LY; Qian DH; Jing HY
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1020-1027. PubMed ID: 29509250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNA-93-5p Promotes Gemcitabine Resistance in Pancreatic Cancer Cells by Targeting the PTEN-Mediated PI3K/Akt Signaling Pathway.
    Wu Y; Xu W; Yang Y; Zhang Z
    Ann Clin Lab Sci; 2021 May; 51(3):310-320. PubMed ID: 34162560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma.
    Liu J; Wan L; Lu K; Sun M; Pan X; Zhang P; Lu B; Liu G; Wang Z
    PLoS One; 2015; 10(5):e0114586. PubMed ID: 25992654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel human ex vivo model for the analysis of molecular events during lung cancer chemotherapy.
    Lang DS; Droemann D; Schultz H; Branscheid D; Martin C; Ressmeyer AR; Zabel P; Vollmer E; Goldmann T
    Respir Res; 2007 Jun; 8(1):43. PubMed ID: 17567922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasome inhibition sensitizes non-small-cell lung cancer to gemcitabine-induced apoptosis.
    Denlinger CE; Rundall BK; Keller MD; Jones DR
    Ann Thorac Surg; 2004 Oct; 78(4):1207-14; discussion 1207-14. PubMed ID: 15464472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT/β-catenin signaling pathway.
    Xia Y; He Z; Liu B; Wang P; Chen Y
    Mol Med Rep; 2015 Sep; 12(3):4530-4537. PubMed ID: 26059239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA MEG3 promotes cisplatin sensitivity of cervical cancer cells by regulating the miR-21/PTEN axis.
    Du Y; Geng G; Zhao C; Gao T; Wei B
    BMC Cancer; 2022 Nov; 22(1):1145. PubMed ID: 36344947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of gemcitabine-resistant human non-small cell lung cancer A549 cells.
    Ikeda R; Vermeulen LC; Lau E; Jiang Z; Sachidanandam K; Yamada K; Kolesar JM
    Int J Oncol; 2011 Feb; 38(2):513-9. PubMed ID: 21152861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA ASAP1-IT1 promotes cell proliferation, invasion and metastasis through the PTEN/AKT signaling axis in non-small cell lung cancer.
    Zhang L; Shi SB; Zhu Y; Qian TT; Wang HL
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):142-149. PubMed ID: 29364481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of chemosensitivity by WEE1 inhibition in EGFR-TKIs resistant non-small cell lung cancer.
    Liu D; Cao Z; Xu W; Lin G; Zhou X; Ding X; Wang N; Wu C; Su B
    Biomed Pharmacother; 2019 Sep; 117():109185. PubMed ID: 31387179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gemcitabine in RRM1-negative advanced refractory non-small cell lung cancer (NSCLC): a case report].
    Zhao M; Yang H; He J
    Zhongguo Fei Ai Za Zhi; 2011 Jun; 14(6):550-3. PubMed ID: 21645463
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.